Cancer treatment Flashcards
(37 cards)
what does radiation do
kills rapidly dividing tumor cells including tumor cells in adjacent tissues
what does chemo do
kills rapidly dividing cells
what does hormone therapy do
inhibits the growth and survival of hormone dependent tumor cells
what does targeted therapy do
specifically inhibit processes required for tumor cell grwowth
what does immunotherapy do
recruits immune system to attack tumor cells
what is the toxicity scale
1= mild
2= mod
3= severe
4= disabling/life threat
5= death
what is myelosuppresion (treatment side effect)
-can result from cancer itself or chemo/radiation
-suppress all diff cell types in the myeloid line
-WBC (focus on neutrophils), platelets, RBC
-most common dose-limiting toxicity
-onset depends on lifespan of blood cells
-drug, dose regimen specific
what is neutropenia
side effect of tx
-due to radiation or chemo which destroys cells that grow at a fast rate
-can’t eat fresh fruit, have fllowers and cant leave their room because of the risk of contamination
management:
=wash hands, minimize exposure from sick people and crowds
side effect: bone pain
what is thrombocytopenia
low levels of platelets
-normal: 150,,000-350,000
-consider fall risk and muscle trauma (resistance exercise)
-CV: therapy contraindicated of values <50,000 bc at risk of bleeding so be careful with plyos and resistance training
-watch for: incraesed bruising, prolonged bleeind gimt,e concomitant medications
they should not be on bed rest
-treatment: platelet transfusions
what is anemia
-fatigue and cardiac symptoms
-risk factors: tx, malignancy, age, hemoglobin level, comobriditiea
-CV: <7-8
management:
-RBC infusions
-erthropoetic stimulating agents: increase risk of blood clot
what is alopecia
loss of hair-scalp first
-onset 1-2 weeks, max 3 weeks
-reversible; growth 2-3 months
-risk varies by class
lowest: hormones, targeted agents
low/mod: antimetablites, platinum agents
high: class alklyating agents
very hihg: taxanes
what is diarrhea
-muscosa of GI tract has a high cell turnover rate
-lose a lot of body water
chronic:
-occurs more than 24 hours after treament
-watch for dehyrations and hypovolumia
-treat ewith anti diarrheals
what is breakthrough nausea
occurs despite appropriate emetic prophylaxis therapy
what is refractory nausea
occurs despite prophylaxis and breakthrouhg emesis treatment
what is chemo brain
-found in up to 75% of paitents
-subtle shifts in cog function
-may be seen early or late
-mechanism unknown
effects:
-difficulty concenrtating, handling performing multiple tasks, short term memoruy
what are grades 1-2 toxicity
-accepted by oncology providers
most common
-dose reduction not warranted
what are grades 3-4 toxciity
-hold doses to permit recovery
-reduce subsequent doses
-prevention important if possible
-impariments are likely permanent
what do taxanes do
-interfere with mitosis
-bind to stabilized microtubules interfering with disaessmebly
what do vinka alkaloids do
-interefre with mitosis
-inhibit microtubule assembly
what are the side effects of taxanes and vinka alkaloids
-peripheral neuropathy
-motor and/or sensory impairments
-stocking and glove: symmetric pareesthesia
-motor nerve impairment that leads to…. loss of DTR and ataxia, paralysis, foot and wrist drop, irreversible or minimallt reversible
-cardiotoxicity: aryyhtmias, hypotension, HF
what are alkylating agents mechanism of action
-prevent cell division by cross linking DNA strands (S phase)
-cell continues to synthesize other cell things like RNA and protein and imablance occurs and the cell dies (G1/G2)
what are the side effects of alkylating agents
- myelosuppression: primary dose limiting toxicity like leukopenia
- hemorhagic cystitis: common in poor hydrated or renal disease, manifest as hematuria
- cardiotoxitity; decline in LV systolic function
- neurotoxicity; encephalopathy= cerebellar ataxia, confusion, hallucinations
what is anthracycline
-prevents cell division by intercalation between DNA pairs (S phase)
-inhibits DNA replication
side effects: cardiotoxiity
acute: arryhytmias and pericarditis
chronic: congestive cardiomyopathy and HF
talk about doxorubicin and HF risk
HF risk increases with escalating dose of doxorubicin